G
Gemma Moncunill
Researcher at University of Barcelona
Publications - 96
Citations - 2434
Gemma Moncunill is an academic researcher from University of Barcelona. The author has contributed to research in topics: Medicine & Vaccination. The author has an hindex of 21, co-authored 71 publications receiving 1503 citations. Previous affiliations of Gemma Moncunill include International Military Sports Council & Harvard University.
Papers
More filters
Journal ArticleDOI
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.
Alberto L. García-Basteiro,Alberto L. García-Basteiro,Gemma Moncunill,Marta Tortajada,Marta Vidal,Caterina Guinovart,Alfons Jiménez,Rebeca Santano,Sergi Sanz,Susana Méndez,Anna Llupià,Ruth Aguilar,Selena Alonso,Diana Barrios,Carlo Carolis,Pau Cisteró,Eugenia Chóliz,Angeline Cruz,Silvia Fochs,Chenjerai Jairoce,Chenjerai Jairoce,Jochen Hecht,Montserrat Lamoglia,M. Martinez,Robert A. Mitchell,Natalia Ortega,Nuria Pey,Laura Puyol,Marta Ribes,Neus Rosell,Patricia Sotomayor,Sara Torres,Sarah R. Williams,Sonia Barroso,Anna Vilella,Jose Muñoz,Antoni Trilla,Pilar Varela,Alfredo Mayor,Alfredo Mayor,Carlota Dobaño +40 more
TL;DR: A relatively low seroprevalence of antibodies among HCW at the peak of the COVID-19 epidemic in Spain is reported, which calls for active periodic rRT-PCR testing in hospital settings.
Journal ArticleDOI
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial.
Carlos Chaccour,Carlos Chaccour,Carlos Chaccour,Aina Casellas,Andrés Blanco-Di Matteo,Iñigo Pineda,Alejandro Fernández-Montero,Paula Ruiz-Castillo,Mary-Ann Richardson,Mariano Rodríguez-Mateos,Carlota Jordán-Iborra,Joe Brew,Francisco Carmona-Torre,Miriam Giráldez,Ester Laso,Juan C. Gabaldon-Figueira,Carlota Dobaño,Gemma Moncunill,Gemma Moncunill,Jose Yuste,José Luis del Pozo,N. Regina Rabinovich,N. Regina Rabinovich,Verena Schöning,Felix Hammann,Gabriel Reina,Gabriel Reina,Belén Sádaba,Mirian Fernández-Alonso +28 more
TL;DR: Among patients with mild COVID-19 and no risk factors for severe disease receiving a single 400 mcg/kg dose of ivermectin within 48 hours of fever or cough onset there was no difference in the proportion of PCR positives and a marked reduction of anosmia/hyposmia, a reduction of cough and a tendency to lower viral loads and lower IgG titers which warrants assessment in larger trials.
Posted ContentDOI
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
Alberto L. García-Basteiro,Gemma Moncunill,Marta Tortajada,Marta Vidal,Caterina Guinovart,Alfons Jiménez,Rebeca Santano,Sergi Sanz,Susana Méndez,Anna Llupià,Rugh Aguilar,Selena Alonso,Diana Barrios,Carlo Carolis,Pau Cisteró,Eugenia Chóliz,Angeline Cruz,Silvia Fochs,Chenjerai Jairoce,Jochen Hecht,Montserrat Lamoglia,M. Martinez,Rob Mitchell,Natalia Ortega,Nuria Pey,Laura Puyol,Marta Ribes,Neus Rosell,Patricia Sotomayor,Sara Torres,Sarah R. Williams,Sonia Barroso,Anna Vilella,Jose Muñoz,Pilar Varela,Antoni Trilla,Alfredo Mayor,Carlota Dobaño +37 more
TL;DR: Estimating the seroprevalence of antibodies against SARS-CoV-2 and associated factors in HCW from a large referral hospital in Barcelona, Spain is aimed at anticipating these estimates to be an upper limit to the seropoulos of the general population.
Journal ArticleDOI
Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy.
Carlota Dobaño,Carlota Dobaño,Hector Sanz,Hermann Sorgho,David Dosoo,Maximilian Mpina,Maximilian Mpina,Maximilian Mpina,Itziar Ubillos,Ruth Aguilar,Tom Ford,Núria Díez-Padrisa,Nana Aba Williams,Aintzane Ayestaran,Ousmane Traore,Augusto Nhabomba,Chenjerai Jairoce,John N. Waitumbi,Selidji T Agnandji,Simon Kariuki,Salim Abdulla,John J. Aponte,John J. Aponte,Benjamin Mordmüller,Kwaku Poku Asante,Seth Owusu-Agyei,Halidou Tinto,Joseph J. Campo,Joseph J. Campo,Gemma Moncunill,Gemma Moncunill,Ben Gyan,Clarissa Valim,Clarissa Valim,Clarissa Valim,Claudia Daubenberger,Claudia Daubenberger +36 more
TL;DR: IgG avidity to the C-terminus of CSP is significantly associated with vaccine-mediated protection and emerges as a significant contributor to RTS,S/AS01E- mediated protection.
Journal ArticleDOI
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses.
Natalia Ortega,Marta Ribes,Marta Vidal,Rocío Rubio,Ruth Aguilar,Sarah R. Williams,Diana Barrios,Selena Alonso,Pablo Hernández-Luis,Robert A. Mitchell,Chenjerai Jairoce,Angeline Cruz,Alfons Jiménez,Rebeca Santano,Susana Méndez,Montserrat Lamoglia,Montserrat Lamoglia,Neus Rosell,Anna Llupià,Laura Puyol,Jordi Chi,Natalia Rodrigo Melero,Daniel Parras,Pau Serra,Edwards Pradenas,Benjamin Trinité,Julià Blanco,Alfredo Mayor,Sonia Barroso,Pilar Varela,Anna Vilella,Antoni Trilla,Pere Santamaria,Carlo Carolis,Marta Tortajada,Luis Izquierdo,Ana Angulo,Pablo Engel,Alberto L. García-Basteiro,Gemma Moncunill,Carlota Dobaño +40 more
TL;DR: In this paper, the authors describe antibody levels and neutralization activity in healthcare workers over seven months and investigate the role of immunity to endemic human coronavirus causing common cold (HCoV) causing COVID-19 disease.